We will have limited operations from 15:00 Wednesday 24 December 2025 (AEDT) until Friday 2 January 2026. Find out how to contact us during the holiday period.
Use the filters below to narrow your search.
Filter results
You can narrow down the results using the filters.
Topic
- (-) Advertising (272)
- COVID-19 (163)
- Safety monitoring and information (96)
- Legislation (93)
- Compliance and enforcement (65)
- Manufacturing (52)
- Vaping hub (51)
- Labelling and packaging (35)
- Scheduling (national classification system) (27)
- Import and export (26)
- Medicinal cannabis hub (25)
- Sunscreens (16)
- Shortages and supply disruptions (14)
- Weight loss products (14)
- Committees and advisory bodies (9)
- Cosmetics (5)
- Unique Device Identification (UDI) hub (4)
- Clinical trials (3)
- Fees and payments (2)
- Prescription opioids hub (2)
- Urogynaecological (transvaginal) surgical mesh hub (2)
- Breast implant hub (1)
Search
272 result(s) found, displaying 251 to 272
-
Media releasesCaruso's Natural Health pays $12,600 fine for false certification in relation to therapeutic good
-
Media releasesJuice Plus Company Australia Pty Ltd has paid penalties of $37,800 for alleged advertising breaches relating to vitamin products
-
Media releasesInSkin Cosmedics Group Pty Ltd has paid penalties of $37,800 in regards to the alleged supply and advertising of the Dermapen 4
-
Media releasesPharmacies and others can advertise availability of OTC salbutamol products during the bushfire season
-
Regulatory decision noticesOn 20 November 2019 the TGA issued a direction notice to Cat Media concerning its advertising of Fatblaster Clinical
-
Media releasesMundipharma Pty Ltd has paid penalties of $302,400 in response to 24 infringement notices issued by the TGA
-
Media releasesConsumer Healthcare Products Australia to handle all medicine advertising pre-approval applications
-
Media releasesThe Complementary Healthcare Council of Australia is no longer accepting advertising pre-approval applications
-
Media releasesThe Therapeutic Goods Administration is aware that a member of the public has purported to be a Commonwealth public official during a recent incident in Melbourne
-
Media releasesChanges are coming in November to the advertising pre-approval arrangements for some complementary medicines advertisements
-
Media releasesThe TGA has commenced work on a sector-wide compliance activity relating to the advertising of bioresonance devices
-
Regulatory decision noticesDirection Notice issued to cease advertising of therapeutic goods not entered in the ARTG
-
Regulatory decision noticesDirection Notice issued to cease advertising of unregistered therapeutic goods to consumers
-
Media releasesThe Federal Court has imposed substantial penalties on Peptide Clinics Australia
-
Media releasesReasons for releasing guidance and how it was developed
-
Media releasesCourt action continues against Peptide Clinics Australia for alleged advertising breaches
-
News articlesDo your research before consenting to live blood analysis, electrodermal testing and other related tests
-
Update to the advertising complaints and investigation information database improves search features
Media releasesThis update implements feedback from stakeholders to make the database more user-friendly -
Regulatory decision noticesDirection Notice issued to cease advertisement of prescription and illegal products
-
Media releasesThis legal action follows an investigation by the Therapeutic Goods Administration
-
Regulatory decision noticesTGA issues advertising direction
-
Media releasesConsumers can now report dodgy ads for medicines and medical devices through a single online form